These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 9770649

  • 1. NMR study and comparison of the antigenic properties of a peptide recognized by two HIV-1 neutralizing antibodies.
    Tsang P, Mu X, Wu G, Durda PJ.
    J Mol Recognit; 1997; 10(6):256-61. PubMed ID: 9770649
    [Abstract] [Full Text] [Related]

  • 2. Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.
    Zvi A, Feigelson DJ, Hayek Y, Anglister J.
    Biochemistry; 1997 Jul 15; 36(28):8619-27. PubMed ID: 9214308
    [Abstract] [Full Text] [Related]

  • 3. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
    Chakraborty K, Durani V, Miranda ER, Citron M, Liang X, Schleif W, Joyce JG, Varadarajan R.
    Biochem J; 2006 Nov 01; 399(3):483-91. PubMed ID: 16827663
    [Abstract] [Full Text] [Related]

  • 4. Induced fit in HIV-neutralizing antibody complexes: evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization.
    Rosen O, Chill J, Sharon M, Kessler N, Mester B, Zolla-Pazner S, Anglister J.
    Biochemistry; 2005 May 17; 44(19):7250-8. PubMed ID: 15882063
    [Abstract] [Full Text] [Related]

  • 5. Expression, purification, and isotope labeling of a gp120 V3 peptide and production of a Fab from a HIV-1 neutralizing antibody for NMR studies.
    Sharon M, Görlach M, Levy R, Hayek Y, Anglister J.
    Protein Expr Purif; 2002 Apr 17; 24(3):374-83. PubMed ID: 11922753
    [Abstract] [Full Text] [Related]

  • 6. A cis proline turn linking two beta-hairpin strands in the solution structure of an antibody-bound HIV-1IIIB V3 peptide.
    Tugarinov V, Zvi A, Levy R, Anglister J.
    Nat Struct Biol; 1999 Apr 17; 6(4):331-5. PubMed ID: 10201400
    [Abstract] [Full Text] [Related]

  • 7. HIV-1 peptide vaccine candidates: selecting constrained V3 peptides with highest affinity to antibody 447-52D.
    Mester B, Manor R, Mor A, Arshava B, Rosen O, Ding FX, Naider F, Anglister J.
    Biochemistry; 2009 Aug 25; 48(33):7867-77. PubMed ID: 19552398
    [Abstract] [Full Text] [Related]

  • 8. NMR studies of V3 peptide complexes with antibodies suggest a mechanism for HIV-1 co-receptor selectivity.
    Sharon M, Rosen O, Anglister J.
    Curr Opin Drug Discov Devel; 2005 Sep 25; 8(5):601-12. PubMed ID: 16159022
    [Abstract] [Full Text] [Related]

  • 9. Structure-based design of a constrained peptide mimic of the HIV-1 V3 loop neutralization site.
    Ghiara JB, Ferguson DC, Satterthwait AC, Dyson HJ, Wilson IA.
    J Mol Biol; 1997 Feb 14; 266(1):31-9. PubMed ID: 9054968
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Molecular characterization of the circulating anti-HIV-1 gp120-specific B cell repertoire using antibody phage display libraries generated from pre-selected HIV-1 gp120 binding PBLs.
    Koefoed K, Farnaes L, Wang M, Svejgaard A, Burton DR, Ditzel HJ.
    J Immunol Methods; 2005 Feb 14; 297(1-2):187-201. PubMed ID: 15777942
    [Abstract] [Full Text] [Related]

  • 15. Glycosylation affects both the three-dimensional structure and antibody binding properties of the HIV-1IIIB GP120 peptide RP135.
    Huang X, Barchi JJ, Lung FD, Roller PP, Nara PL, Muschik J, Garrity RR.
    Biochemistry; 1997 Sep 09; 36(36):10846-56. PubMed ID: 9312273
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Structural studies of human HIV-1 V3 antibodies.
    Stanfield RL, Wilson IA.
    Hum Antibodies; 2005 Sep 09; 14(3-4):73-80. PubMed ID: 16720977
    [Abstract] [Full Text] [Related]

  • 18. The binding of a glycoprotein 120 V3 loop peptide to HIV-1 neutralizing antibodies. Structural implications.
    Wu G, MacKenzie R, Durda PJ, Tsang P.
    J Biol Chem; 2000 Nov 24; 275(47):36645-52. PubMed ID: 10967109
    [Abstract] [Full Text] [Related]

  • 19. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM, McKeating JA, de Souza JB, Roitt IM, Delves PJ, Lund T.
    Virology; 1998 Nov 10; 251(1):59-70. PubMed ID: 9813203
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.